← Back to Search

Exercise Timing for Breast Cancer

N/A
Recruiting
Led By Adriana M Coletta, PhD, MS, RD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, on average four weeks
Awards & highlights

Study Summary

This trial will explore the feasibility and acceptability of assigning breast cancer survivors on chemo to exercise at a specific time of day (morning/afternoon). Outcome data will be used for a larger trial.

Who is the study for?
This trial is for Stage I-III breast cancer patients who are about to start chemotherapy or have just started it, meaning they've received only one cycle. Participants should be able to perform daily activities with varying degrees of assistance (ECOG 0, 1, 2). Those with advanced cancer (Stage IV) or greater disability (ECOG ≥3), or who have had more than one chemo cycle cannot join.Check my eligibility
What is being tested?
The study tests the feasibility and acceptability of assigning breast cancer survivors on chemotherapy to exercise at specific times of day—either morning or afternoon/evening—for four weeks. It aims to inform a larger future trial by examining how this schedule affects physical function and performance.See study design
What are the potential side effects?
Since the intervention in this study is exercise timing rather than a drug, side effects may include typical exercise-related issues such as muscle soreness or fatigue. However, these will vary based on individual health status and response to chemotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and through study completion, on average four weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and through study completion, on average four weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of the intervention
Secondary outcome measures
Acceptability
Cardiorespiratory fitness
Lower body physical function
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Morning GroupExperimental Treatment1 Intervention
Participants must start their exercise between the hours of 5am and 10am.
Group II: Evening GroupExperimental Treatment1 Intervention
Participants must start their exercise between the hours of 3pm and 8pm.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,778,590 Total Patients Enrolled
14 Trials studying Breast Cancer
7,084 Patients Enrolled for Breast Cancer
Adriana M Coletta, PhD, MS, RDPrincipal InvestigatorUniversity of Utah

Media Library

Exercise Timing Groups Clinical Trial Eligibility Overview. Trial Name: NCT05821244 — N/A
Breast Cancer Research Study Groups: Morning Group, Evening Group
Breast Cancer Clinical Trial 2023: Exercise Timing Groups Highlights & Side Effects. Trial Name: NCT05821244 — N/A
Exercise Timing Groups 2023 Treatment Timeline for Medical Study. Trial Name: NCT05821244 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial currently taking place?

"This clinical trial, initially posted on July 5th 2023 and recently updated on the 7th of July, is currently recruiting patients. Information regarding this can be found online at clinicaltrials.gov."

Answered by AI

How many individuals have been registered for this clinical research?

"Correct. According to information available on clinicaltrials.gov, this medical research project was first made public on July 5th 2023 and its details have been updated most recently on the 7th of July 2023. 40 volunteers are still needed from 1 site in order for the study to move forward."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Exercise Timing in Breast Cancer Patients
Adriana Coletta 2023. "Exercise Timing in Breast Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05821244.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top